Kitty’s work focuses on supporting clients on inorganic M&A growth agendas, from pre-transaction, execution to value-creation topics. Additionally, she leverages her five years line experience in the health industry to help clients on operational transformation and commercial innovation topics.
Healthcare in Asia is exciting because it is one that is in tremendous need for change, where the status quo is not sustainable – this is where my focus on deal transactions and transformation topics such as digital innovations (and associated challenges!) are incredibly relevant.
Prior to Oliver Wyman, Kitty worked at Zuellig Pharma in a Corporate Development role and was a former investment banker at BofAML based out of London and HK. Kitty holds a Masters in Business Administration from London Business School. She is a health and fitness enthusiast, having trained in weight lifting, gymnastics strength and Muay Thai.